Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-118

I've never said a friendly takeover is impossible. I've always spoken about hostile takeover.

BUT the company approach has always been to offer partnerships, that way the technology won't be parked.

We have entire families of patents in the hundreds. Now SI is NOT going to want to have all those families technology bought out by one party who isn't going to use it all.

Why? Humanitarian reasons. So what you're saying goes against the way that SI has moved and how I believe he thinks as a humanitarian first and foremost.

Multiple partnerships involving exclusivity are however, entirely possible. Just so long as the maximum applications of the technology get rolled out for unmet needs.

We've had far too many delays from the likes of Teva, and with painfully slow caution by the FDA and the implementation of a stem cells protocol developed in conjunction with the FDA.

Now it's time to really MOVE!!!